MML Investors Services’s Bone Biologics BBLG Stock Holding History

MML Investors Services’s Portfolio BBLG Stock Details BBLG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-313	Closed	-$11K	–	2446
2023 Q3	$11K	Buy	+313	New	+$15.5K	﹤0.01%	2292

Other funds holding BBLG

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MML Investors Services's BBLG Position: Q4 2023 in Review

MML Investors Services sold out of Bone Biologics (BBLG) in Q4 2023, closing a stake of 313 shares — an estimated $11K sold.

MML Investors Services first reported a position in BBLG in Q3 2023 and held it in 1 quarter. The position peaked at $11K in Q3 2023. 2 funds tracked by Wall St. Rank hold BBLG as of Q4 2023.

MML Investors Services reported no remaining Bone Biologics position as of Q4 2023 after selling out during the quarter.
MML Investors Services sold 313 Bone Biologics shares in Q4 2023, an estimated $11K.
MML Investors Services first reported a position in Bone Biologics in Q3 2023 and held it in 1 quarter.
MML Investors Services's Bone Biologics position peaked at $11K in Q3 2023.
2 funds tracked by Wall St. Rank held Bone Biologics as of Q4 2023.

Based on MML Investors Services's 13F filing for Q4 2023, filed 14 Feb 2024.